Target engagement of the first-in-class CXCR7 antagonist ACT-1004-1239 following multiple-dose administration in mice and humans

by Christine Huynh, Janneke M. Brussee, Laetitia Pouzol, Marlene Fonseca, Henriette E. Meyer zu Schwabedissen, Jasper Dingemanse, Patricia N. Sidharta
Published 2021